Search Results 781-790 of 18219 for Immunode

  1. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

    Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive; Hypersensitivity to pegfilgrastim or Escherichia (E.) coli ...

  2. A Study of Using Mesenchymal Stem Cells Developed from the Patients Own Fat Tissue for Reducing Hemodialysis Arteriovenous Fistula Failure - Mayo Clinic

    Immunodeficiency including AIDS / HIV or Active autoimmune disease. Documented hypercoagulable state or history of 2 or more DVTs or other spontaneous ...

  3. MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery - Mayo Clinic

    Known immune deficiency, including human immunodeficiency virus (HIV) infection; History of systemic autoimmune disease, as patients with ongoing ...

  4. Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris - Mayo Clinic

    Participation eligibility · Vulnerable study population · Pregnant or nursing women · Women planning a pregnancy within the study period · Human immunodeficiency ...

  5. Immune-mediated adverse events - Mayo Clinic

    CT chest scan, PET-CT scan and transbronchoscopic biopsy indicating immune-mediated adverse events. Share · Tweet . IMG-20400457.

  6. ABSORB III Randomized Controlled Trial (RCT) - Mayo Clinic

    ... immunodeficiency virus, systemic lupus erythematosus, etc.). Note: corticosteroids are not included as immunosuppressant therapy. Subject has previously ...

  7. TheraSphere With and Without Durvalumab and Tremelimumab for HCC - Mayo Clinic

    Patients with Human Immunodeficiency Virus (HIV) infection are ... immunodeficiency virus (HIV 1/2 antibodies) plus HCV or HBV co-infection. 26 ...

  8. A Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) - Mayo Clinic

    eligible. 6. Known history of human immunodeficiency virus or known seropositive for hepatitis C virus or hepatitis B virus. 7. Active uncontrolled gastric ...

  9. A Study to Evaluate the Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

    Patients with known history of human immunodeficiency virus (HIV) infection. Any other clinically significant cardiovascular, gastrointestinal, hepatic ...

  10. Publications - Maheen Z. Abidi, M.B.B.S., M.D. - Mayo Clinic

    ... immunodeficiency. Transpl Infect Dis. 2024 Aug; 26 (4):e14287 Epub 2024 May 02. View PubMed; Abidi MZ, Umbleja T, Overton ET, Burdo T, Flynn JM, Lu MT, Taron ...